✦ LIBER ✦

Recurrence of hepatocellular carcinoma after liver transplantation: Is immunosuppression a factor?

✍ Scribed by Myron Schwartz; Manoussos Konstadoulakis; Sasan Roayaie

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 52 KB
Volume: 11
Category: Article
ISSN: 1527-6465
DOI: 10.1002/lt.20413

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of recurrent hepatocellular ca

Treatment of recurrent hepatocellular carcinoma after liver transplantation

✍ Eric Davis; Russell Wiesner; Juan Valdecasas; Yoshiaki Kita; Massimo Rossi; Myro 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 1 views

Analysis of risk factors for tumor recur

Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: Key role of immunosuppression

✍ Marco Vivarelli; Alessandro Cucchetti; Fabio Piscaglia; Giuliano La Barba; Luigi 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

To confirm recent observations about the relationship between immunosuppression and the recurrence of hepatocellular carcinoma (HCC) after liver transplantation (LT), we retrospectively analyzed 70 consecutive HCC patients who underwent LT and received cyclosporine (CsA) -based immunosuppression. Cs

Accelerated growth rates of recurrent he

Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation

✍ Yokoyama, Itsuo (author);Carr, Brian (author);Saitsu, Hideki (author);Iwatsuki, 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 455 KB 👁 2 views

Accelerated growth rates of recurrent he

Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation

✍ Yokoyama, Itsuo (author);Carr, Brian (author);Saitsu, Hideki (author);Iwatsuki, 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 455 KB 👁 2 views

Recurrence of hepatocellular carcinoma a

Recurrence of hepatocellular carcinoma after liver transplant: Patterns and prognosis

✍ Sasan Roayaie; Jonathan D. Schwartz; Max W. Sung; Sukru H. Emre; Charles M. Mill 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 1 views

Very little is known about the natural history, effects of therapy, and survival after recurrence of hepatocellular carcinoma (HCC) after liver transplantation. All adult patients undergoing liver transplant from September 19, 1988, until September 19, 2002, were reviewed. Only patients with histolo

Sirolimus-based immunosuppression is ass

Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma

✍ Christian Toso; Shaheed Merani; David L. Bigam; A.M. James Shapiro; Norman M. Kn 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB 👁 1 views

Liver transplantation is an important treatment option for selected patients with nonresectable hepatocellular carcinoma (HCC). Several reports have suggested a lower risk of posttransplant tumor recurrence with the use of sirolimus and a higher one with calcineurin inhibitors, but the selection of